Horizon Pharma (HZNP) Affirms FY 2016 Net Sales Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Brean Capital Cuts Price Target After Horizon Pharma (HZNP) Releases Soft Guidance
April 14, 2016 9:40 AM EDTBrean Capital maintained a Buy rating on Horizon Pharma (NASDAQ: HZNP), and cut the price target to $30.00 (from $32.00), after the company provided soft 1Q and 2Q guidance. The company now expects to generate 19-20%/22-23%/57-59% of FY16 sales vs. previous consensus estimates of... More
UBS Cuts Price Target on Horizon Pharma (HZNP) After Meeting with Management
April 13, 2016 8:20 AM EDTUBS maintained a Buy rating on Horizon Pharma (NASDAQ: HZNP), and cut the price target to $24.00 (from $39.00), after meeting with management. Horizon is expecting the 1H16 to be slower than 2H16 as it needs to absorb the deductibles that patients cover before drug... More
Piper Jaffray Remains Bullish on Horizon Pharma (HZNP) as Stock Loses Value
April 13, 2016 7:55 AM EDTPiper Jaffray maintained an Overweight rating and $44.00 price target on Horizon Pharma (NASDAQ: HZNP) after the stock loses over a quarter of its value following detail from management regarding the cadence of expected quarterly results. Management cited a higher than expected gross-to-net spreads as one driver associated with lower 1Q16 EPS contribution versus other... More
